DEA Comments Gaffe
The DEA (Drug Enforcement Agency) has ordained its decree: Another year, another decrease in the production quota for prescription opioids.
Stop Sensationalizing Respiratory Viruses
Instead of using sensationalistic terminology, it would be more helpful to focus on accurate information when discussing respiratory viruses.
Illegal Immigration Burdens the c
One area that is particularly affected is the American healthcare system, both in terms of financial strain and clinical outcomes.
Physicians: Write Legal Briefs
In recent years, there has been an increasing need for physicians to participate in complex healthcare legal cases by writing...
What’s Next for the Obesity Industrial Complex
The future of the obesity industry is not in novel drugs or new forms of therapy, but in combining existing...
Black Swans of Health Policy
Don’t worry about the healthcare laws. Worry about the changing legal interpretations of existing healthcare laws.
Make the Patient Encounter a Conversation
The patient encounter, the heart of healthcare, is unique in its speed and complexity, unlike any other setting found in...
What’s in Store for 2024?
Daily Remedy has new features launching in 2024 to enhance the patient experience and cultivate educational opportunities for physicians.
Achieve Success with Dry January
Setting goals and making resolutions for the new year is something that many people do. However these goals are forgotten...
Addiction Isn’t Just Genetic
The impact of behavioral factors on addiction is a complex and multifaceted topic that continues to be researched and explored.
For the Love of 4am
Many individuals are constantly searching for ways to maximize their output and achieve more in their personal and professional lives.
The Gut Healthy Diet
Emerging research suggests that our microbial composition can impact our nutritional needs and even influence our dietary choices.
Videos
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more